Latest Kidney and genitourinary system biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

New Inmunotherpay strategy in non-clear cell renal cell cancer

by VHIO

1 year ago
ipilimumab plus nivolumab, non-clear cell renal cell cancer

The phase 2 international multicenter SUNNIFORECAST study is the first prospective randomized trial evaluating dual immunotherapy with ipilimumab plus nivolumab against standard-of-care (SOC) tyrosine...

El Hospital de Bellvitge transforma la atención a la enfermedad renal crónica para mejorar la sostenibilidad y reducir el impacto ambiental

by Hospital Universitari de Bellvitge

1 year ago
enfermedad renal crónica, Hospital de Bellvitge

El Hospital Universitario de Bellvitge se ha unido desde principios de este año 2025 al proyecto Green Nephrology, que consiste en una transformación de la atención a la enfermedad renal crónica d...

IDIBELL and Bellvitge Hospital receive funding to improve tolerance in kidney transplants

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

12 months ago
kidney transplants

The objective is to identify new mechanisms to reduce the risk of rejection of the transplanted organ and improve the quality of life of patients.

An aggressive childhood cancer case opens new avenues for advanced cell therapies

by IRB Barcelona - Instituto de Investigación Biomédica

12 months ago
Rhabdoid tumours, T cells, Cellular immunotherapy, TCR-T, immune checkpoint inhibitors (ICI)

After receiving chemotherapy and radiotherapy, the patient also began immunotherapy with immune checkpoint inhibitors (ICI), a treatment that boosts the ability of lymphocytes to recognise and combat ...

Una investigadora del Cima Universidad de Navarra recibe la prestigiosa ‘ERC Starting Grant’ para desarrollar terapia génica para enfermedades renales

by CIMA - Centro de Investigación Médica Aplicada

10 months ago
proyecto RENALGENE, poliquistosis renal autosómica dominante (PQRAD)

Este trabajo del grupo Desarrollo de Tecnologías de Transferencia de Genes del Cima Universidad de Navarra desarrollará terapias génicas personalizadas para mejorar la calidad de vida de los pacien...

IDIBAPS-Hospital Clínic’s spin-off MiWEndo Solutions obtains 1.2 million euros to develop a new device to diagnose types of polyps during colonoscopies

by Fundació Clínic per a la Recerca Biomèdica

10 months ago
MiWEndo Solutions, endoscopic diagnostics

MiWEndo Solutions is a spin-off of Pompeu Fabra University (UPF), the Polytechnical University of Catalonia (UPC), IDIBAPS-Hospital Clínic and the Catalan Institution for Research and Advanced Studie...

Biomarcadores inflamatorios y de estrés oxidativo están asociados con la aparición de la enfermedad renal crónica en personas con obesidad y síndrome metabólico

by Professional Newco

10 months ago
enfermedad renal crónica (ERC), marcadores inflamatorios (IL-6, IL-1β o TNFα), marcadores daño oxidativo (malondialdehído, MDA)

Los resultados mostraron que, ya desde el inicio, quienes acabaron desarrollando ERC tenían niveles más altos de marcadores inflamatorios (IL-6, IL-1β o TNFα) y de daño oxidativo (malondialdehíd...

First evidence of a ‘nearly universal’ pharmacological chaperone for rare disease

by Centre for Genomic Regulation

9 months ago
vasopressin V2 receptor (V2R), nephrogenic diabetes insipidus (NDI), tolvaptan, G-protein-coupled receptors (GPCRs)

A study published today in Nature Structural & Molecular Biology is the first time researchers have shown evidence that a single drug, already licensed for medical use, can stabilise nearly all mutate...

AM-Pharma Completes Enrollment in Phase 2 Study of Ilofotase Alfa for Prevention of Cardiac Surgery-Associated Renal Damage

by Ysios Capital

9 months ago
Ilofotase Alfa, cardiac surgery-associated renal damage (CSA-RD).

AM-Pharma B.V. today announced that it has successfully completed enrollment of patients in its ongoing Phase 2 clinical trial evaluating ilofotase alfa for the prevention of cardiac surgery-associate...

KEYMAKER-U03 sub-study 03A: triplet investigational combinations of immunotherapy and targeted treatments as first-line therapy for advanced renal cell carcinoma

by VHIO

8 months ago
advanced clear cell renal cell carcinoma (ccRCC), pembrolizumab

Results from sub-study 03A of KEYMAKER-U03, an international, open-label, rolling-arm, phase I/II umbrella trial, spotlight the promise of pembrolizumab-based regimens combined with tyrosine kinase (T...

IBIMA lidera un ensayo que mejora la salud y bienestar en pacientes con ERC avanzada gracias a la educación nutricional

by Bionand

8 months ago
enfermedad renal crónica (ERC), educación nutricional “coaching”

La investigación, liderada por equipos de IBIMA, el Hospital Regional Universitario de Málaga, la Universidad de Málaga y el CIBERDEM, revela beneficios en el bienestar, la composición corporal y ...

First transplant in pigs of modified porcine kidneys with human renal organoids

by IBEC - Institut de Bioenginyeria de Catalunya

8 months ago
human renal organoids, regenerative medicine

A research team has developed pioneering technology that enables human kidney organoids to be produced on a scalable basis. These organoids can then be combined with pig kidneys outside the body and t...